Metered Dose Inhaler Devices Pipeline Market Research Report: Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update [Yahoo! Finance]
Verona Pharma plc - American Depositary Shares (VRNA)
US:NASDAQ Investor Relations:
nasdaq.com/symbol/vrna/real-time
Company Research
Source: Yahoo! Finance
Countries, Regulatory Path and Key Companies, 2024 Update" report has been added to ResearchAndMarkets.com's offering. The analyst report provides comprehensive information about the Metered Dose Inhaler Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. Metered dose inhaler devices deliver a specific amount of medication to the lungs. A metered-dose inhaler consists of a canister, the metering valve and an actuator. Scope Extensive coverage of the Metered Dose Inhaler Devices under development The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities The report reviews the major players involved in the development of Metered Dose Inhaler Devices and list all their pipeline projects The coverage of pipeline products based on various stages of development r
Show less
Read more
Impact Snapshot
Event Time:
VRNA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VRNA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VRNA alerts
High impacting Verona Pharma plc - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
VRNA
News
- Verona Pharma to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Corporate Update [Yahoo! Finance]Yahoo! Finance
- Verona Pharma to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Corporate UpdateGlobeNewswire
- Verona Pharma plc (NASDAQ: VRNA) had its price target raised by analysts at Canaccord Genuity Group Inc. from $44.00 to $72.00. They now have a "buy" rating on the stock.MarketBeat
- Nuance Pharma Announces Approval of Ohtuvayre™ (ensifentrine) in Macau SAR, ChinaPR Newswire
- Global Airway Clearance Devices for Cystic Fibrosis Market to Show Positive Growth at a CAGR of ~5% by 2032 | DelveInsightPR Newswire
VRNA
Sec Filings
- 2/14/25 - Form SCHEDULE
- 2/14/25 - Form SCHEDULE
- 2/4/25 - Form 4
- VRNA's page on the SEC website